Single microdose trial - CXCR4 PET tracer - Pharmacokinetics and pharmacodynamics of [68Ga]Ga-R54, a CXCR4-targeted radiopharmaceutical in patients with advanced solid tumors.

2024-513303-14-00 Protocol R4-FOUR-PET Human pharmacology (Phase I) - First administration to humans Ongoing, recruiting

Start 8 Jan 2025 · Status Ongoing, recruiting · 1 EU/EEA countries · 1 sites · Protocol R4-FOUR-PET

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - First administration to humans
Status Ongoing, recruiting
Participants planned 10
Countries 1
Sites 1

Advanced solid neoplasm (breast, lung, colon, ovary, pancreas) characterized by positive CXCR4 expression by immunohistochemistry

Key facts

Sponsor
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Neoplasms [C04]
Trial duration
8 Jan 2025 → ongoing
Decision date (initial)
2024-10-15
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
No

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Advanced solid neoplasm (breast, lung, colon, ovary, pancreas) characterized by positive CXCR4 expression by immunohistochemistry

VersionLevelCodeTermSystem organ class
21.1 LLT 10065411 PET/CT scan 10022891
21.1 LLT 10065252 Solid tumor 10029104

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

IRCCS Istituto Nazionale Tumori Fondazione Pascale

Sponsor organisation
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Address
Via Mariano Semmola 52
City
Naples
Postcode
80131
Country
Italy

Scientific contact point

Organisation
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Contact name
Secondo Lastoria

Public contact point

Organisation
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Contact name
Stefania Scala

Locations

1 EU/EEA country · 1 investigational sites

By country

CountryMS statusPlanned subjectsSites
Italy Ongoing, recruiting 10 1
Rest of world 0

Investigational sites

Italy

1 site · Ongoing, recruiting
IRCCS Istituto Nazionale Tumori Fondazione Pascale
Nuclear Medicine Unit, Via Mariano Semmola 52, 80131, Naples

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Italy 2025-01-08 2025-01-24

Application history

2 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-07-05 Italy Acceptable
2024-10-10
2024-10-15
2 SUBSTANTIAL MODIFICATION SM-1 2026-02-20 Italy Acceptable
2026-04-16
2026-04-20